Dov A Md Goldstein insider trades: BioAge Labs (BIOA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dov reports to the SEC
and 4 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | BIOA | ↓ Sell | 27,000 | $19.70 | $532K | Direct | Jan 15, 2026 (2d) |
| Jun 18, 2021 | NBSE | ↑ Buy | 8,000 | $4.75 | $38K | Direct | Jun 21, 2021 (3d) |
| Apr 26, 2021 | NBSE | ↑ Buy | 12,000 | $5.00 | $60K | Direct | Apr 27, 2021 (1d) |
| Apr 30, 2020 | NBSE | ↑ Buy | 10,000 | $6.00 | $60K | Direct | May 4, 2020 (4d) |
| Mar 22, 2017 | ESPR | ↓ Sell | 800,000 | $41.66 | $33.3M | By Aisling Capital II, LP | Mar 23, 2017 (1d) |
| Mar 8, 2017 | CEMP | ↓ Sell | 150,000 | $3.55 | $533K | By Aisling Capital II, LP | Mar 9, 2017 (1d) |
| Jan 13, 2017 | CEMP | ↓ Sell | 105,460 | $3.40 | $359K | By Aisling Capital II, LP | Jan 18, 2017 (5d) |
| Jan 6, 2017 | CEMP | ↓ Sell | 937,600 | $3.41 | $3.2M | By Aisling Capital II, LP | Jan 6, 2017 (0d) |
| Jan 4, 2016 | CEMP | ↓ Sell | 842 | $30.06 | $25K | Direct | Jan 6, 2016 (2d) |
| Jun 22, 2015 | CEMP | ↓ Sell | 50,000 | $35.74 | $1.8M | Direct | Jun 24, 2015 (2d) |
| Apr 24, 2015 | ESPR | ↓ Sell | 217,469 | $108.22 | $23.5M | By Aisling Capital II, LP | Apr 27, 2015 (3d) |
| Aug 6, 2014 | LOXO | ↑ Buy | 413,077 | $13.00 | $5.4M | Held by Aisling Capital III, LP | Aug 6, 2014 (0d) |
| Aug 6, 2014 | LOXO | ↑ Buy | 413,077 | $13.00 | $5.4M | Direct | Aug 6, 2014 (0d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 238,119 | $14.00 | $3.3M | By Aisling Capital II, LP | Jul 1, 2013 (0d) |
| Jul 24, 2012 | DRTX | ↑ Buy | 1,111,111 | $9.00 | $10.0M | By Aisling Capital III, LP | Jul 25, 2012 (1d) |
| Feb 7, 2012 | CEMP | ↑ Buy | 1,213,663 | $6.00 | $7.3M | By Aisling Capital II, LP | Feb 9, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BIOA insiders
Open-market trades in the last 12 months
About Dov A Md Goldstein's insider trades
Dov A Md Goldstein is Chief Financial Officer at BioAge Labs (BIOA). Since Feb 7, 2012, Dov has reported 8 open-market purchases worth $31.5M and 8 sales worth $63.3M on SEC Form 4. In the last 12 months: 1 sale ($532K).
Their filings also include grants and awards (36 filings), option exercises (10 filings), other transactions (8 filings), conversions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.